Yi-Ping Fu,Indu Kohaar,Lee E. Moore,Petra Lenz,Jonine D. Figueroa,Wei Tang,Patricia Porter-Gill,Nilanjan Chatterjee,Alexandra Scott-Johnson,Montserrat Garcia-Closas,Brian Muchmore,Dalsu Baris,Ashley Paquin,Kris Ylaya,Molly Schwenn,Andrea B. Apolo,Margaret R. Karagas,McAnthony Tarway,Alison Johnson,Adam Mumy,Alan Schned,Liliana Guedez,Michael A. Jones,Masatoshi Kida,GM Monawar Hosain,Nuria Malats,Manolis Kogevinas,Adonina Tardon,Consol Serra,Alfredo Carrato,Reina Garcia-Closas,Josep Lloreta,Xifeng Wu,Mark Purdue,Gerald L. Andriole,Robert L. Grubb,Amanda Black,Maria T. Landi,Neil E. Caporaso,Paolo Vineis,Afshan Siddiq,H. Bas Bueno-de-Mesquita,Dimitrios Trichopoulos,Börje Ljungberg,Gianluca Severi,Elisabete Weiderpass,Vittorio Krogh,Miren Dorronsoro,Ruth C. Travis,Anne Tjønneland,Paul Brennan,Jenny Chang-Claude,Elio Riboli,Jennifer Prescott,Constance Chen,Immaculata De Vivo,Edward Govannucci,David Hunter,Peter Kraft,Sara Lindstrom,Susan M. Gapstur,Eric J. Jacobs,W. Ryan Diver,Demetrius Albanes,Stephanie J. Weinstein,Jarmo Virtamo,Charles Kooperberg,Chancellor Hohensee,Rebecca J. Rodabough,Victoria K. Cortessis,David V. Conti,Manuela Gago-Dominguez,Mariana C. Stern,Malcolm C. Pike,David Van Den Berg,Jian-Min Yuan,Christopher A. Haiman,Olivier Cussenot,Geraldine Cancel-Tassin,Morgan Roupret,Eva Comperat,Stefano Porru,Angela Carta,Sofia Pavanello,Cecilia Arici,Giuseppe Mastrangelo,H. Barton Grossman,Zhaoming Wang,Xiang Deng,Charles C. Chung,Amy Hutchinson,Laurie Burdette,William Wheeler,Joseph Fraumeni,Stephen J. Chanock,Stephen M. Hewitt,Debra T. Silverman,Nathaniel Rothman,Ludmila Prokunina-Olsson

Table S1 from FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis Via Cyclin E1/CDK2–Mediated Phosphorylation of CENP-A

Figure S1-S7 from FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis Via Cyclin E1/CDK2–Mediated Phosphorylation of CENP-A

Data from FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis Via Cyclin E1/CDK2–Mediated Phosphorylation of CENP-A

Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Supplementary Table 7 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Table S1 from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Sequential Posttranslational Modifications Program FEN1 Degradation During Cell-Cycle Progression

LARP7 is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis

Supplementary Table 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Table 1 from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by <i>LKB1</i> Loss

Supplementary Table 5 from The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease

Clinical significance of FBXW7 loss of function in human cancers

Supplementary Materials, Figures 1 - 3, Tables 1 - 4, 6 - 8 from the 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease

Supplementary Tables S1-S4 from Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution

SCF FBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction

Supplementary Materials, Methods and Tables from Downregulation of <i>safb</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>tak1</i> During the Progression of Colorectal Cancer

Correction: Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia

Supplementary Table from Proteomic Mapping and Targeting of Mitotic Pericentriolar Material in Tumors Bearing Centrosome Amplification